Editorial: Circulating biomarkers in prostate cancer

被引：0
作者：
Nagata, Masayoshi [1 ]
Horie, Shigeo [1 ,2 ]
Ma, Yafeng [3 ]
机构：
[1] Juntendo Univ, Grad Sch Med, Dept Urol, Tokyo, Japan
[2] Juntendo Univ, Dept Adv Informat Genet Dis, Digital Therapeut, Grad Sch Med, Tokyo, Japan
[3] Univ New South Wales, Ingham Inst Appl Med Res, Sch Clin Med, Liverpool, NSW, Australia
来源：
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词：
prostate cancer; biomarkers; diagnosis; prognosis; liquid biopsy; circulating tumour cells;
D O I：
10.3389/fonc.2024.1365353
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 9 条
  • [1] AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
    Antonarakis, Emmanuel S.
    Lu, Changxue
    Wang, Hao
    Luber, Brandon
    Nakazawa, Mary
    Roeser, Jeffrey C.
    Chen, Yan
    Mohammad, Tabrez A.
    Chen, Yidong
    Fedor, Helen L.
    Lotan, Tamara L.
    Zheng, Qizhi
    De Marzo, Angelo M.
    Isaacs, John T.
    Isaacs, William B.
    Nadal, Rosa
    Paller, Channing J.
    Denmeade, Samuel R.
    Carducci, Michael A.
    Eisenberger, Mario A.
    Luo, Jun
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) : 1028 - 1038
  • [2] Efficacy of cabazitaxel and androgen splicing variant-7 status in circulating tumor cells in Asian patients with metastatic castration-resistant prostate cancer
    Ashizawa, Takeshi
    Nagata, Masayoshi
    Nakamura, So
    Hirano, Hisashi
    Nagaya, Naoya
    Lu, Yan
    Horie, Shigeo
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [3] Clinical Relevance of Circulating Tumor Cells in Prostate Cancer Management
    Cieslikowski, Wojciech A.
    Antczak, Andrzej
    Nowicki, Michal
    Zabel, Maciej
    Budna-Tukan, Joanna
    [J]. BIOMEDICINES, 2021, 9 (09)
  • [4] Prognostic and Predictive Value of Liquid Biopsy-Derived Androgen Receptor Variant 7 (AR-V7) in Prostate Cancer: A Systematic Review and Meta-Analysis
    Khan, Tanzila
    Becker, Therese M.
    Scott, Kieran F.
    Descallar, Joseph
    de Souza, Paul
    Chua, Wei
    Ma, Yafeng
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Genome-wide studies in prostate cancer poised liquid biopsy as a molecular discovery tool
    Lo, Nicholas
    He, Housheng Hansen
    Chen, Sujun
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [6] An Insight on Novel Molecular Pathways in Metastatic Prostate Cancer: A Focus on DDR, MSI and AKT
    Mollica, Veronica
    Marchetti, Andrea
    Rosellini, Matteo
    Nuvola, Giacomo
    Rizzo, Alessandro
    Santoni, Matteo
    Cimadamore, Alessia
    Montironi, Rodolfo
    Massari, Francesco
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
  • [7] How the Analysis of the Pathogenetic Variants of DDR Genes Will Change the Management of Prostate Cancer Patients
    Sciarra, Alessandro
    Frisenda, Marco
    Bevilacqua, Giulio
    Gentilucci, Alessandro
    Cattarino, Susanna
    Mariotti, Gianna
    Del Giudice, Francesco
    Di Pierro, Giovanni Battista
    Viscuso, Pietro
    Casale, Paolo
    Chung, Benjamin I.
    Autorino, Riccardo
    Crivellaro, Simone
    Salciccia, Stefano
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)
  • [8] Prognostic Value of Geriatric Nutritional Risk Index for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Shen, Fangfang
    Ma, Yong
    Guo, Wei
    Li, Feng
    [J]. LUNG, 2022, 200 (05) : 661 - 669
  • [9] Geriatric Nutritional Risk Index and Survival of Patients With Colorectal Cancer: A Meta-Analysis
    Zhao, Haiming
    Xu, Li
    Tang, Peng
    Guo, Rui
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
1